Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome

This study has been completed.
Sponsor:
Information provided by:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00688506
First received: May 29, 2008
Last updated: July 2, 2012
Last verified: July 2012
  Purpose

Treatment of chronic pelvic pain syndrome (CPPS) is challenging for patients and physicians once conventional therapies fail.

We hypothesize that combined sono-electro-magnetic therapy can improve refractory CPPS in men. In addition, we postulate that combined sono-electro-magnetic therapy as well as placebo therapy has a significant effect on brain activity detectable by functional MRI.


Condition Intervention
Chronic Pelvic Pain Syndrome
Device: combined sono-electro-magnetic therapy (Sonodyn Medico Star)
Device: placebo therapy (Placebo Sonodyn Medico Star)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome: A Prospective, Randomized, Double-blind, Placebo-controlled Trial

Resource links provided by NLM:


Further study details as provided by University Hospital Inselspital, Berne:

Primary Outcome Measures:
  • National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) [ Time Frame: before treatment, after 6 and 12 weeks of treatment as well as 4 weeks after stop of treatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Brain activity assessed by functional MRI [ Time Frame: before treatment, after 12 weeks of treatment ] [ Designated as safety issue: No ]
  • Comparison of MRI of CPPS patients versus MRI of age-/sex-matched controls of the local neuro-radiology MRI database [ Time Frame: before treatment ] [ Designated as safety issue: No ]

Enrollment: 60
Study Start Date: November 2009
Study Completion Date: July 2012
Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Combined sono-electro-magnetic therapy
Device: combined sono-electro-magnetic therapy (Sonodyn Medico Star)
twice a day for 10 minutes during 12 weeks
Other Name: Sonodyn Medico Star
Placebo Comparator: 2
placebo therapy
Device: placebo therapy (Placebo Sonodyn Medico Star)
twice a day for 10 minutes during 12 weeks
Other Name: Placebo Sonodyn Medico Star device

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • CPSS III
  • symptomatic >3 months
  • NIH-CPSI total score =/>15
  • NIH-CPSI pain =/>8

Exclusion Criteria:

  • post void residual >100mL
  • urinary tract infection
  • urethral stricture
  • prostate cancer
  • age <18 years
  • claustrophobia
  • pacemaker, neurostimulator, insulin / pain pump
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00688506

Locations
Switzerland
Department of Urology, University of Bern
Bern, Switzerland, 3010
Sponsors and Collaborators
University Hospital Inselspital, Berne
Investigators
Principal Investigator: Thomas M Kessler, MD Department of Urology, University of Bern, 3010 Switzerland
  More Information

No publications provided

Responsible Party: Thomas M. Kessler, MD, Department of Urology, University of Bern, 3010 Bern
ClinicalTrials.gov Identifier: NCT00688506     History of Changes
Other Study ID Numbers: KEK 292/07, 1492
Study First Received: May 29, 2008
Last Updated: July 2, 2012
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital Inselspital, Berne:
Chronic pelvic pain syndrome
Neuromodulation
Brain effects
Neuroimaging

Additional relevant MeSH terms:
Syndrome
Somatoform Disorders
Pelvic Pain
Disease
Pathologic Processes
Mental Disorders
Pain
Signs and Symptoms

ClinicalTrials.gov processed this record on September 18, 2014